- Quality (50% of total score) - Select at least 6 MIPS measures including one Outcome measure (or high priority measure if an outcome measure is not applicable to your practice) and report them on 60% of the eligible patient visits for the entire year:
- #5 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)*
- #6 Coronary Artery Disease (CAD): Antiplatelet Therapy*
- #7 Coronary Artery Disease (CAD): Beta-Blocker Therapy - Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)*
- #8 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)*
- #47 Care Plan* - High Priority
- #110 Preventive Care and Screening: Influenza Immunization
- #118 Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)*
- #128 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan *
- #130 Documentation of Current Medications in the Medical Record *Note: This measure is reported on every patient visit (vs. once per reporting period). High Priority
- #204 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic*
- #226 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention*
- #236 Controlling High Blood Pressure* Outcome
- #238 Use of High-Risk Medications in the Elderly* High Priority
- #243 Cardiac Rehabilitation Patient Referral from an Outpatient Setting* High Priority
- #317 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented*
- #322 Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients * High Priority
- #323 Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI)*High Priority
- #324 Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients* High Priority
- #326 Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy*
- #344 Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2) * Outcome
- #345 Rate of Postoperative Stroke or Death in Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS) * Outcome
- #348 HRS-3: Implantable Cardioverter-Defribrillator (ICD) Complications Rate** Outcome
- #374 Closing the Referral Loop: Receipt of Specialist Report *High Priority
- #392 HRS-12: Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation** Outcome
- #393 HRS-9: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision** Outcome
- #402 Tobacco Use and Help with Quitting Among Adolescents*
- #431 Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling*
- #438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease*
- #441 Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control) * Outome
- #442 Persistence of Beta-Blocker Treatment After a Heart Attack * Outcome
- *These 26 registry measures make-up the Cardiology Specialty Measures set.
- **These 3 registry measures make-up the Electrophysiology Cardiac Specialists Specialty Measures Set
- Advancing Care Information (25% of total score) - Replaces the Medicare EHR Incentive Program also known as Meaningful Use:
- Improvement Activities (15% of total score) - Attest that you completed up to 2 high-weighted activities or 4 medium-weighted activities for a minimum of 90 days. Groups with fewer than 15 participants or if you are in a rural or health professional shortage area: Attest that you completed 1 high-weighted or 2 medium-weighted activities for a minimum of 90 days:
- Collection and use of patient experience and satisfaction data on access (medium weighted).
- Annual registration in the Prescription Drug Monitoring Program (medium weighted).
- Engagement of new Medicaid patients and follow-up (high-weighted).
- Engage patients and families to guide improvement in the system of care (medium weighted).
- Implementation of documentation improvements for practice/process improvements (medium weighted).
- Implementation of improvements that contribute to more timely communication of test results (medium weighted).
- Anticoagulant management improvements (high weighted).
- Participate in systematic anticoagulation program (high weighted).
- Other resources from CMS: MIPS Measures Guide for Cardiologists: Highlights a non-exhaustive sample of measures and activities for the Quality, Improvement Activities, and Advancing Care Information performance categories that may apply to cardiologists in 2017.
